Home › Funds › D. E. Shaw & Co › GILD
D. E. Shaw & Co position in GILD
GILEAD SCIENCES INC · Health Care
Latest position (Q2 2026)2.49M sh
Reported value held$313.97M
Portfolio Weight0.16%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 542.50K | $37.89M | New |
| Q4 2021 | 1.48M | $107.74M | Add |
| Q1 2022 | 6.47M | $384.38M | Add |
| Q2 2022 | 2.35M | $145.39M | Reduce |
| Q3 2022 | 538.64K | $33.23M | Reduce |
| Q4 2022 | 2.56M | $220.00M | Add |
| Q1 2023 | 2.56M | $212.65M | Hold |
| Q2 2023 | 2.50M | $192.68M | Reduce |
| Q3 2023 | 2.76M | $206.48M | Add |
| Q4 2023 | 1.38M | $111.93M | Reduce |
| Q1 2024 | 1.37M | $100.23M | Reduce |
| Q2 2024 | 3.69M | $252.98M | Add |
| Q3 2024 | 1.15M | $96.81M | Reduce |
| Q4 2024 | 1.32M | $122.38M | Add |
| Q1 2025 | 643.86K | $72.14M | Reduce |
| Q2 2025 | 827.93K | $91.79M | Add |
| Q3 2025 | 549.66K | $61.01M | Reduce |
| Q4 2025 | 300.40K | $36.87M | Reduce |
| Q1 2026 | 220.92K | $30.79M | Reduce |
| Q2 2026 | 2.49M | $313.97M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GILD
- BlackRock Inc 121.84M sh · $15.39B · Q2 2026
- Vanguard Group 121.10M sh · $14.86B · Q4 2025
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- Geode Capital Management 30.07M sh · $3.80B · Q2 2026
- Morgan Stanley 24.00M sh · $3.03B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- Norges Bank Investment Management 21.97M sh · $2.78B · Q2 2026
- Capital Research Global Investors 19.39M sh · $2.45B · Q2 2026
- Bank of America Corp 18.65M sh · $2.36B · Q2 2026
- BNY Mellon 15.28M sh · $1.93B · Q2 2026